Please select the option that best describes you:
Topics:
Chronic kidney disease • Nephrology
Do you prioritize adding a GLP-1 receptor agonist over an SGLT-2 inhibitor in patients with CKD related to type 2 diabetes, uncontrolled proteinuria despite being on an ACEi, and obesity?
Answer from: at Community Practice
My habit to date has been to use an SGLT-2 inhibitor first. I refer patients to PCPs or others for GLP-1 treatment for obesity, even if they have CKD.
Sign in or Register to read more